{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:11:43Z","timestamp":1790255503972,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1 DA015815"],"award-info":[{"award-number":["UG1 DA015815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3 DA044831"],"award-info":[{"award-number":["UH3 DA044831"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014848","name":"Arnold Ventures","doi-asserted-by":"publisher","award":["20-04132"],"award-info":[{"award-number":["20-04132"]}],"id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jsat.2021.108483","type":"journal-article","created":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T01:27:27Z","timestamp":1621128447000},"page":"108483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Mobile methadone medication units: A brief history, scoping review and research opportunity"],"prefix":"10.1016","volume":"129","author":[{"given":"Brian","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bougatsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Grusing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jsat.2021.108483_bb0005","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1360-0443.1990.tb01598.x","article-title":"The \u201cmethadone by bus\u201d project in Amsterdam","volume":"85","author":"Buning","year":"1990","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.jsat.2021.108483_bb0010","series-title":"The mobile methadone medication program: A study of an innovative service delivery system for drug abuse treatment","author":"Center for Addictive Behaviors","year":"1994"},{"issue":"2","key":"10.1016\/j.jsat.2021.108483_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/00952990802647495","article-title":"Residential treatment modifications: Adjunctive services to accommodate clients on methadone","volume":"35","author":"Chen","year":"2009","journal-title":"American Journal of Drug & Alcohol Abuse"},{"key":"10.1016\/j.jsat.2021.108483_bb0020","series-title":"Registration requirement for narcotic treatment program with mobile components (21 CFR parts 1300, 1301 and 1304)","author":"Department of Justice, D. E. A","year":"2020"},{"issue":"2","key":"10.1016\/j.jsat.2021.108483_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0376-8716(96)01273-2","article-title":"Patient retention in mobile and fixed-site methadone maintenance treatment","volume":"42","author":"Greenfield","year":"1996","journal-title":"Drug & Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2021.108483_bb0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jsat.2013.11.002","article-title":"Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals","volume":"46","author":"Hall","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2021.108483_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0740-5472(02)00343-4","article-title":"Feasibility of referring drug users from a needle exchange program into an addiction treatment program: Experience with a mobile treatment van and LAAM maintenance","volume":"24","author":"Kuo","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108483_bb0040","author":"McBournie"},{"key":"10.1016\/j.jsat.2021.108483_bb0045","series-title":"Methadone treatment regulations in the United States: History, current status, evidence, and policy considerations","author":"McCarty","year":"2020"},{"key":"10.1016\/j.jsat.2021.108483_bb3045","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2021.20101548","article-title":"Office-based methadone treatment for opioid use disorder and pharmacy dispensing: A scoping review","author":"McCarty","year":"2021","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2021.108483_bb0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Medical Research Methodology"},{"key":"10.1016\/j.jsat.2021.108483_bb0055","series-title":"The Biden-Harris administration's statement of drug policy priorities for year one","author":"Office of National Drug Control Policy","year":"2021"},{"key":"10.1016\/j.jsat.2021.108483_bb0060","series-title":"American Association for the Treatment of Opioid Dependence on registration requirements for narcotic treatment programs with mobile component (RIN 1117-AB43\/Docket No. DEA-459)","author":"Parrino","year":"2020"},{"key":"10.1016\/j.jsat.2021.108483_bb0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.drugalcdep.2008.09.009","article-title":"Methadone patients in the therapeutic community: A test of equivalency","volume":"100","author":"Sorensen","year":"2009","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108483_bb0070","doi-asserted-by":"crossref","unstructured":"Sucharew, H., & Macaluso, M. (2019). Progress notes: Methods for research evidence synthesis: The scoping review approach. Journal of Hospital Medicine (Online), 14(7), 416-418. Doi:10.12788\/jhm.3248.","DOI":"10.12788\/jhm.3248"},{"key":"10.1016\/j.jsat.2021.108483_bb0075","author":"Vestal"},{"key":"10.1016\/j.jsat.2021.108483_bb0080","author":"Wroblewski"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221002099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221002099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:55:34Z","timestamp":1760039734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221002099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":17,"alternative-id":["S0740547221002099"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108483","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mobile methadone medication units: A brief history, scoping review and research opportunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108483"}}